SPARTAN Archives - Medical Conferences

Intrinsic tumour biology may be predictive of treatment response in prostate cancer

Presented By

Prof. Felix Feng, University of California San Francisco, USA

Trial

Phase 3, SPARTAN

Conference

ASCO GU 2021

Type

Peer-reviewed article

24 March 2021 14:46

Early initiation of lasmiditan improves migraine outcomes

Presented By

Dr Mario F. Peres, Hospital Israelita Albert Einstein, Brazil

Trial

Phase 3, GLADIATOR

Conference

MTIS 2020

27 October 2020 15:11

ARAMIS final OS and nmCRPC safety outcomes

Expert

Prof. Karim Fizazi, Institut Gustave Roussy, France

Trial

Phase 3, ARAMIS

Conference

ASCO 2020

Type

Peer-reviewed article

17 September 2020 14:11

Final survival results from phase 3 SPARTAN trial

Expert

Prof. Eric J. Small, University of California San Francisco, CA, USA

Trial

Phase 3, SPARTAN

Conference

ASCO 2020

17 September 2020 14:01

25% reduction in the risk of death in patients with nmCRPC treated with apalutamide

Presented By

Prof. Matthew Smith, Massachusetts General Hospital, Boston, USA

Trial

Phase 3, SPARTAN

Conference

ESMO 2019

Type

Peer-reviewed article

26 November 2019 23:23

Lasmiditan in migraine patients with CV risk factors

Trial

Phase 3, SAMURAI and SPARTAN

Conference

EAN 2019

Type

Peer-reviewed article

27 August 2019 18:18